BIONOMICS LIMITED - AMERICAN DEPOSITORY SHARES

Bionomics Limited Announces Private Placement of up to $70.0 Million

31 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting

20 5 2024 06:30:00 提供 Nasdaq GlobeNewswire

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder

21 3 2024 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics to Present at the 2024 BIO CEO & Investor Conference

22 2 2024 16:30:00 提供 Nasdaq GlobeNewswire

Bionomics Provides a Review of 2023 and of 2024 Plans

22 1 2024 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics to Present at Biotech Showcase™ 2024

05 1 2024 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting

06 12 2023 08:00:00 提供 Nasdaq GlobeNewswire

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder

16 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

28 9 2023 06:00:52 提供 Nasdaq GlobeNewswire

Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD

14 9 2023 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210

23 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

31 7 2023 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth

03 7 2023 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics to Present at Upcoming June Investor Conferences

15 6 2023 08:00:01 提供 Nasdaq GlobeNewswire

Bionomics Announces Upcoming Poster Presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

30 5 2023 06:00:00 提供 Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

28 4 2023 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics Announces the Completion of Enrollment in Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

27 4 2023 06:00:00 提供 Nasdaq GlobeNewswire

Bionomics Reports Promising Full Results Analysis from PREVAIL Phase 2 Study of BNC210 Social Anxiety Disorder (SAD)

08 3 2023 19:00:30 提供 Nasdaq GlobeNewswire

Bionomics’ Half-Year Report

23 2 2023 06:00:00 提供 Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

30 1 2023 18:23:46 提供 Nasdaq GlobeNewswire